Carlos Alberola-López

Elena Martín-González, Ebraham Alskaf, Amedeo Chiribiri et al.

First-pass perfusion cardiac magnetic resonance (FPP-CMR) is becoming an essential non-invasive imaging method for detecting deficits of myocardial blood flow, allowing the assessment of coronary heart disease. Nevertheless, acquisitions suffer from relatively low spatial resolution and limited heart coverage. Compressed sensing (CS) methods have been proposed to accelerate FPP-CMR and achieve higher spatial resolution. However, the long reconstruction times have limited the widespread clinical use of CS in FPP-CMR. Deep learning techniques based on supervised learning have emerged as alternatives for speeding up reconstructions. However, these approaches require fully sampled data for training, which is not possible to obtain, particularly high-resolution FPP-CMR images. Here, we propose a physics-informed self-supervised deep learning FPP-CMR reconstruction approach for accelerating FPP-CMR scans and hence facilitate high spatial resolution imaging. The proposed method provides high-quality FPP-CMR images from 10x undersampled data without using fully sampled reference data.

Pablo Villacorta-Aylagas, Manuel Rodríguez-Cayetano, Carlos Castillo-Passi et al.

We present MRSeqStudio, a new all-in-one web-based tool for MRI sequence development and simulation, with the physics-based simulator KomaMRI running at the back-end and our own sequence designer at the front-end. It combines accessibility, interactivity and technical flexibility, within an environment suitable for both education and research. Our tool provides MR sequence design and simulation as a service, with no local installation needed by the user; alternatively, the code is publicly available on GitHub, for users who wish to deploy the application on their own server.

Patricia Amado-Caballero, Luis Miguel San-José-Revuelta, María Dolores Aguilar-García et al.

This paper proposes an eXplainable Artificial Intelligence (XAI)-driven methodology to enhance the understanding of cough sound analysis for respiratory disease management. We employ occlusion maps to highlight relevant spectral regions in cough spectrograms processed by a Convolutional Neural Network (CNN). Subsequently, spectral analysis of spectrograms weighted by these occlusion maps reveals significant differences between disease groups, particularly in patients with COPD, where cough patterns appear more variable in the identified spectral regions of interest. This contrasts with the lack of significant differences observed when analyzing raw spectrograms. The proposed approach extracts and analyzes several spectral features, demonstrating the potential of XAI techniques to uncover disease-specific acoustic signatures and improve the diagnostic capabilities of cough sound analysis by providing more interpretable results.

Patricia Amado-Caballero, Luis M. San-José-Revuelta, Xinheng Wang et al.

This paper presents an explainable artificial intelligence (XAI)-based framework for the spectral analysis of cough sounds associated with chronic respiratory diseases, with a particular focus on Chronic Obstructive Pulmonary Disease (COPD). A Convolutional Neural Network (CNN) is trained on time-frequency representations of cough signals, and occlusion maps are used to identify diagnostically relevant regions within the spectrograms. These highlighted areas are subsequently decomposed into five frequency subbands, enabling targeted spectral feature extraction and analysis. The results reveal that spectral patterns differ across subbands and disease groups, uncovering complementary and compensatory trends across the frequency spectrum. Noteworthy, the approach distinguishes COPD from other respiratory conditions, and chronic from non-chronic patient groups, based on interpretable spectral markers. These findings provide insight into the underlying pathophysiological characteristics of cough acoustics and demonstrate the value of frequency-resolved, XAI-enhanced analysis for biomedical signal interpretation and translational respiratory disease diagnostics.